Amniopatch treatment for preterm premature rupture of membranes before23 weeks' gestation and factors associated with its success

Collection with item attached
2017
Item details URL
http://open-repository.kisti.re.kr/cube/handle/open_repository/474490.do
DOI
10.1016/j.tjog.2017.08.005
Title
Amniopatch treatment for preterm premature rupture of membranes before23 weeks' gestation and factors associated with its success
Description
This study was supported by grants of the Korea Healthcare TechnologyR&D Project (grant number: A102065 and grant number: HI14C0306) throughthe Korea Health Industry Development Institute (KHIDI), funded by theMinistry of Health & Welfare, Republic of Korea.
abstract
Objective: The purpose of this study is to investigate the factors associated with successful amniopatch treatment in patients with iatrogenic preterm premature rupture of membranes (iPPROM) or spontaneous PPROM (sPPROM) before 23 weeks' gestation.
Materials and methods: This cohort study included 28 women who received amniopatch treatment due to iPPROM or sPPROM at 15-23 weeks' gestation. Patients' clinical characteristics before performing the amniopatch, factors associated with the procedure, pregnancy and neonatal outcomes were compared between the iPPROM and sPPROM groups, and also between the successful and failed groups.
Results: The amniopatch was successful in 6 of 28 patients (21.4%) with a success rate of 36.4% (4/11) and 11.8% (2/17) in the iPPROM group and sPPROM group (P = 0.174), respectively. The success group had a longer PPROM-to-delivery interval, fewer cases of clinical chorioamnionitis, larger birth weight, and lower neonatal intensive care unit admission rate than the failed group. The success rate of amniopatch procedure was proportional to maximal vertical pocket prior to procedure, which showed statistically significant association (adjusted odds ratio: 3.62, 95% confidence interval: 1.16-11.31, P = 0.027).
Conclusion: The amniopatch treatment success rate was higher in the iPPROM group than the sPPROM group, but was not statistically significant. The neonatal outcome was more favorable when the amniopatch was successful. However, the only predictive factor associated with successful amniopatch was a larger amniotic fluid volume before the procedure. (C) 2017 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.
provenance
Made available in Cube on 2018-09-28T10:47:26Z (GMT). No. of bitstreams: 0
language
English
author
Sung, Ji-Hee
Kuk, Jin-Yi
Cha, Hyun-Hwa
Choi, Suk-Joo
Oh, Soo-young
Roh, Cheong-Rae
Kim, Jong-Hwa
accessioned
2018-09-28T10:47:26Z
available
2018-09-28T10:47:26Z
issued
2017
citation
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY(56): 5
issn
1028-4559
uri
http://open-repository.kisti.re.kr/cube/handle/open_repository/474490.do
Funder
보건복지부
Funding Program
임상연구인프라조성
Project ID
1355062377
Jurisdiction
Rep.of Korea
Project Name
Amniopatch treatment for pre-viable preterm premature rupture of membranes
rights
openAccess
subject
Amniopatch latrogenic preterm premature rupture of membranes
Before 23weeks' gestation
Spontaneous preterm premature rupture of membranes
type
article


Files in This Item

There are no attached files.